ATLANTA, Jan. 31 /PRNewswire-FirstCall/ -- CryoLife, Inc. (NYSE: CRY), a biomaterials, medical device and tissue processing company, announced today that fourth quarter and year end 2007 financial results will be released on Thursday, February 21, 2008. The Company will hold a teleconference call and live webcast at 10:00 a.m. Eastern Time, February 21, 2008, to discuss the results followed by a question and answer session hosted by Steven G. Anderson, president and chief executive officer of CryoLife, Inc.
To listen to the live teleconference please dial 201-689-8261 a few minutes prior to 10:00 a.m. A replay of the teleconference will be available February 21 through February 28, 2008 and can be accessed by calling (toll free) 877-660-6853 or 201-612-7415. The account number for the replay is 244 and the conference number is 271923.
The live webcast and replay can be accessed by going to the Investor Relations section of the CryoLife Web site at http://www.cryolife.com and selecting the heading Webcasts & Presentations.
About CryoLife, Inc.
Founded in 1984, CryoLife, Inc. is a leader in the processing and distribution of implantable living human tissues for use in cardiac and vascular surgeries throughout the United States and Canada. The Company's BioGlue(R) Surgical Adhesive is FDA approved as an adjunct to sutures and staples for use in adult patients in open surgical repair of large vessels. BioGlue is also CE marked in the European Community and approved in Canada and Australia for use in soft tissue repair. The Company also distributes the CryoLife-O'Brien(R) stentless porcine heart valve, which is CE marked for distribution within the European Community.
For additional information about the company, visit CryoLife's Web
D. Ashley Lee
Executive Vice President, Chief Operating Officer and
Chief Financial Officer
|SOURCE CryoLife, Inc.|
Copyright©2008 PR Newswire.
All rights reserved